+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Antibody Drug Conjugates Market Report 2025 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Hemophilia Therapeutics Market 2021-2025 - Product Thumbnail Image

Hemophilia Therapeutics Market 2021-2025

  • Report
  • August 2021
  • 120 Pages
  • Global
From
From
From
South African Vitamins Industry Landscape Report 2022 - Product Thumbnail Image

South African Vitamins Industry Landscape Report 2022

  • Report
  • March 2022
  • 127 Pages
  • South Africa
From
Histoplasmosis Treatment Market Report 2025 - Product Thumbnail Image

Histoplasmosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Anti-CD20 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD20 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Bio/Pharmaceutical Outsourcing Report, May 2025 - Product Thumbnail Image

Bio/Pharmaceutical Outsourcing Report, May 2025

  • Report
  • May 2025
  • 24 Pages
  • Global
From
From
Global Digital Biomarker Market Outlook 2030 - Product Thumbnail Image

Global Digital Biomarker Market Outlook 2030

  • Report
  • June 2021
  • 401 Pages
  • Global
From
From
Loading Indicator